Innovation Pharmaceuticals (EM)【IPIX】銘柄情報

Innovation Pharmaceuticals Inc (EM) (IPIX) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.0003

( - )

買値

0.00

売値

0.00

出来高

0.00 日の範囲 0.00

0.000001 52 週間の範囲 0.05

時価総額

158.63k

前日終値

0.0003

始値

時刻

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

US$ 128,738

発行済株式数

528,765,313

配当利回り

PER

-0.06

1 株当たり利益 (EPS)

-0.01

歳入

純利益

-2.62M

Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel diseas... Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.ipharminc.com

本社

Wakefield, United States

設立

2026

Innovation Pharmaceuticals Inc (EM) is listed in the Healthcare sector of the その他OTC with ticker IPIX. The last closing price for Innovation Pharmaceuticals (EM) was US$0. Over the last year, Innovation Pharmaceuticals (EM) shares have traded in a share price range of US$ 0.000001 to US$ 0.05.

Innovation Pharmaceuticals (EM) currently has 528,765,313 shares in issue. The market capitalisation of Innovation Pharmaceuticals (EM) is US$158,629.59 . Innovation Pharmaceuticals (EM) has a price to earnings ratio (PE ratio) of -0.06.

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 8-K - Current report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

IQST Has Catalysts On Deck That Expose A Valuation Disconnect of Roughly 100% - Here's Why That Gap Should Close

November 5, 2021 -- InvestorsHub NewsWire -- via Hawk Point Media -- Benzinga iQSTEL Inc.’s (OTCQX:IQST) market cap of $62M is...

CEO Presenting on the Emerging Growth Conference on October 13 Register Now

CEO Presenting on the Emerging Growth Conference on October 13 Register Now Niche Companies in Technology, Biotech / Pharma, FinTech, Exploration...

CEO's Presenting on the Emerging Growth Conference 17 TODAY. Register Now

CEO's Presenting on the Emerging Growth Conference 17 TODAY. Register Now Niche Companies in Technology, Biotech / Pharma...

CLS Holdings, (OTCQB: CLSH) New Joint Venture $19 million Sales 61% Growth

CLS Holdings, (OTCQB: CLSH) New Joint Venture $19 million Sales 61% Growth Miami, FL--(September 28, 2021) –...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.0001	-25	0.0004	0.0004	0.0003	75463	0.0003	CS
4	0.0002	200	0.0001	0.0004	0.0001	110725	0.00030053	CS
12	-0.0002	-40	0.0005	0.01	0.0001	119328	0.00035121	CS
26	-0.0007	-70	0.001	0.05	0.0001	141791	0.00064092	CS
52	-0.0007	-70	0.001	0.05	1.0E-6	257661	0.00130938	CS
156	-0.0175	-98.3146067416	0.0178	0.05	1.0E-6	323200	0.00550417	CS
260	-0.2049	-99.8538011696	0.2052	0.54	1.0E-6	697722	0.08231416	CS